Artal Group as of June 30, 2015
Portfolio Holdings for Artal Group
Artal Group holds 61 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals (LXRX) | 19.9 | $463M | 58M | 8.05 | |
| Weight Watchers International | 6.2 | $143M | 29M | 4.85 | |
| Biogen Idec (BIIB) | 6.1 | $141M | 350k | 403.94 | |
| Wal-Mart Stores (WMT) | 5.1 | $118M | 1.7M | 70.93 | |
| Google Inc Class C | 5.0 | $117M | 225k | 520.51 | |
| BioMarin Pharmaceutical (BMRN) | 3.7 | $87M | 635k | 136.78 | |
| Celgene Corporation | 3.0 | $69M | 600k | 115.74 | |
| Goldman Sachs (GS) | 2.7 | $63M | 300k | 208.79 | |
| Bank of America Corporation (BAC) | 2.6 | $60M | 3.5M | 17.02 | |
| Alnylam Pharmaceuticals (ALNY) | 2.4 | $55M | 455k | 119.87 | |
| General Electric Company | 2.3 | $53M | 2.0M | 26.57 | |
| Incyte Corporation (INCY) | 2.1 | $50M | 480k | 104.21 | |
| Alibaba Group Holding (BABA) | 2.1 | $49M | 600k | 82.27 | |
| General Motors Company (GM) | 2.1 | $48M | 1.5M | 33.33 | |
| Yum! Brands (YUM) | 1.9 | $45M | 500k | 90.08 | |
| JPMorgan Chase & Co. (JPM) | 1.8 | $41M | 600k | 67.76 | |
| MasterCard Incorporated (MA) | 1.6 | $37M | 400k | 93.48 | |
| American Express Company (AXP) | 1.5 | $35M | 450k | 77.72 | |
| MetLife (MET) | 1.4 | $34M | 600k | 55.99 | |
| Bluebird Bio (BLUE) | 1.4 | $34M | 200k | 168.37 | |
| Qualcomm (QCOM) | 1.4 | $31M | 500k | 62.63 | |
| Morgan Stanley (MS) | 1.2 | $29M | 750k | 38.79 | |
| Array BioPharma | 1.2 | $29M | 4.0M | 7.21 | |
| Merck & Co (MRK) | 1.2 | $29M | 500k | 56.93 | |
| Amazon (AMZN) | 1.2 | $28M | 65k | 434.09 | |
| Linkedin Corp | 1.2 | $27M | 132k | 206.63 | |
| Teva Pharmaceutical Industries (TEVA) | 1.1 | $27M | 450k | 59.10 | |
| Mobileye | 1.1 | $27M | 500k | 53.17 | |
| American Airls (AAL) | 1.1 | $26M | 650k | 39.94 | |
| Kite Pharma | 1.1 | $26M | 425k | 60.97 | |
| ISIS Pharmaceuticals | 1.0 | $23M | 400k | 57.55 | |
| Citigroup (C) | 0.9 | $22M | 400k | 55.24 | |
| Nektar Therapeutics (NKTR) | 0.9 | $21M | 1.7M | 12.51 | |
| Lendingclub | 0.8 | $20M | 1.3M | 14.75 | |
| McDonald's Corporation (MCD) | 0.8 | $19M | 200k | 95.07 | |
| Micron Technology (MU) | 0.8 | $19M | 1.0M | 18.84 | |
| Agios Pharmaceuticals (AGIO) | 0.8 | $18M | 160k | 111.14 | |
| Aercap Holdings Nv Ord Cmn (AER) | 0.7 | $17M | 375k | 45.79 | |
| Crown Castle Intl (CCI) | 0.7 | $16M | 200k | 80.30 | |
| Hilton Worlwide Hldgs | 0.7 | $15M | 550k | 27.55 | |
| Gilead Sciences (GILD) | 0.5 | $12M | 100k | 117.08 | |
| Jumei Intl Hldg Ltd Sponsored | 0.5 | $11M | 500k | 22.84 | |
| Juno Therapeutics | 0.4 | $10M | 190k | 53.33 | |
| Delta Air Lines (DAL) | 0.3 | $8.2M | 200k | 41.08 | |
| Chemocentryx | 0.3 | $7.4M | 900k | 8.23 | |
| BioTime | 0.3 | $6.8M | 1.9M | 3.63 | |
| Ignyta | 0.3 | $6.8M | 450k | 15.09 | |
| Seres Therapeutics (MCRB) | 0.3 | $6.6M | 160k | 41.50 | |
| Celldex Therapeutics | 0.3 | $6.3M | 250k | 25.22 | |
| XOMA CORP Common equity shares | 0.3 | $6.2M | 1.6M | 3.88 | |
| Agenus (AGEN) | 0.2 | $4.6M | 530k | 8.63 | |
| Realogy Hldgs (HOUS) | 0.2 | $4.7M | 100k | 46.72 | |
| Cellectis S A (CLLS) | 0.2 | $4.5M | 125k | 36.08 | |
| REPCOM cla | 0.1 | $3.5M | 50k | 69.52 | |
| Jd (JD) | 0.1 | $3.4M | 100k | 34.10 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $2.6M | 217k | 12.06 | |
| Parnell Pharmaceuticals Holdin (PARNF) | 0.1 | $2.5M | 500k | 4.95 | |
| Castlight Health | 0.1 | $2.0M | 250k | 8.14 | |
| Ceres | 0.1 | $2.0M | 1.0M | 1.95 | |
| Mirati Therapeutics | 0.1 | $1.9M | 61k | 31.46 | |
| Colucid Pharmaceuticals | 0.0 | $50k | 5.6k | 8.97 |
